• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

69
18
17
17
5

COUNTRY

18
4
1
1

PRICE

615
624
635
695

PUBLISHED

2
3
609
695

PRODUCT TYPE

602
91
2

Genomics

The term Genomics refer to a branch of molecular biology which studies structure, function, evolution, and mapping of genomes. This discipline has a wide range of practical applications in food, agriculture, technology, medicine: it is a dynamic science, far-reaching and abundant with research and business opportunities.

The reports listed under Research and Markets’ Genomics category cover every aspect of commercial genetic activity, including DNA sequencing, gene mining, functional genomics, population-based genomics, bioinformatics, gene therapy, and pharmaceutical and biopharmaceutical concerns. You will find information regarding technologies, products and techniques on the market; R&D and product development; manufacturing statistics; market share and regional/national profiles.

Also available is a selection of scientific texts from acclaimed academics and experts, catering for the needs of a wide readership ranging from undergraduate students to top researchers worldwide. Show Less
Read more

PRODUCT TITLE

Cellular Imaging Market (single cell analysis/Live cell imaging)

Single cell analysis plays an important role in genomics, proteomics, transcriptomics and epigenomics at the single cell level It provides an ultra-sensitive tool to explicate specific molecular mechanisms...

October 2014
FROM

Global Genomics and Proteomics Analytical Instruments Market 2014-2018

About Global Genomics and Proteomics Analytical Instruments Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins...

July 2014
FROM

Genes and Patents: Evolution; Controversies and Perspectives (Technical Insights)

Genes are the constituent elements of a human body Genetic research has been carried out to find answers to several questions pertaining to diseases, drug discovery, diagnostics and therapeutics It...

June 2014
FROM

Analysis of the Western European Next Generation Sequencing (NGS) Market

This study explores Western Europe’s dynamic next generation sequencing (NGS) market The majority of the quantitative and qualitative information was acquired through primary research conducted with...

June 2014
FROM

Cell Analysis Market by Instruments, Consumables & Application- Global Forecast to 2018

'Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction,...

April 2014
FROM

Future of Personalized Genomics--Technical Insights

The future of healthcare is moving towards become more personalized An individual’s genetic information is become a crucial component to assess the risks and predispositions one has towards acquiring...

March 2014
FROM
United Therapeutics Corp,(UTHR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages United Therapeutics Corp,(UTHR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

United Therapeutics Corp,(UTHR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for United Therapeutics Corp (UTHR), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
United-Guardian Inc,(UG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages United-Guardian Inc,(UG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

United-Guardian Inc,(UG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for United-Guardian Inc (UG), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Viralytics Ltd,(VRACY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Viralytics Ltd,(VRACY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Viralytics Ltd,(VRACY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Viralytics Ltd (VRACY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Viropro, Inc.,(VPRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Viropro, Inc.,(VPRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Viropro, Inc.,(VPRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Viropro, Inc. (VPRO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Rigel Pharmaceuticals Inc,(RIGL) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Rigel Pharmaceuticals Inc,(RIGL) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Rigel Pharmaceuticals Inc,(RIGL) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Rigel Pharmaceuticals Inc (RIGL), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Roche Holding Ltd,(RHHBY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Roche Holding Ltd,(RHHBY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Roche Holding Ltd,(RHHBY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Roche Holding Ltd (RHHBY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Shionogi & Co Ltd,(SGIOF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Shionogi & Co Ltd,(SGIOF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Shionogi & Co Ltd,(SGIOF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Shionogi & Co Ltd (SGIOF), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Shire plc,(SHPG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Shire plc,(SHPG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Shire plc,(SHPG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Shire plc (SHPG), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
Star Nutrition Inc,(STAU) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Star Nutrition Inc,(STAU) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Star Nutrition Inc,(STAU) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Star Nutrition Inc (STAU), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
ZIOPHARM Oncology Inc,(ZIOP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages ZIOPHARM Oncology Inc,(ZIOP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

ZIOPHARM Oncology Inc,(ZIOP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ZIOPHARM Oncology Inc (ZIOP), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Anavex Life Sciences Corporation,(AVXL) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Anavex Life Sciences Corporation,(AVXL) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Anavex Life Sciences Corporation,(AVXL) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Anavex Life Sciences Corporation (AVXL), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
AngioGenex, Inc.,(AGGX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages AngioGenex, Inc.,(AGGX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

AngioGenex, Inc.,(AGGX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AngioGenex, Inc. (AGGX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Astellas Pharma, Inc.,(ALPMF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Astellas Pharma, Inc.,(ALPMF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Astellas Pharma, Inc.,(ALPMF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Astellas Pharma, Inc. (ALPMF), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Bayer AG,(BAYRY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Bayer AG,(BAYRY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Bayer AG,(BAYRY) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Bayer AG (BAYRY), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos